George Huffmon, MD
Neurosurgery · Wilmington, NCNPI 1487626560
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $115,336 of the $192,040 with a category attached, or 60.1%. Medtronic accounts for 74.1% of it on its own, with 33 other manufacturers making up the rest. Reporting peaked in 2019 at $54,768 and has fallen 62.6% since, to $20,495 in 2025.
Across 644 payments — averaging $298.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$142K
- Baylis Medical Company Inc$12K
- Globus Medical$10K
- Zimmer Biomet$10K
- Saluda Medical Americas, Inc.$9K
- Boston Scientific$3K
- plus $6K from 28 others
Across 3 payments — averaging $10,833 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$33K
What the payments were for
- Royalty or licence$9,5395%
- Consulting fees$26,07714%
- Speaking & faculty fees$115,33660%
- Travel & lodging$24,17513%
- Food & beverage$16,9139%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 312 | $142,216 |
| Baylis Medical Company Inc | 5 | $12,161 |
| Globus Medical(2 entities) | 34 | $9,690 |
| Zimmer Biomet | 6 | $9,553 |
| Saluda Medical Americas, Inc. | 15 | $9,377 |
| Boston Scientific | 135 | $2,738 |
| Southtech Orthopedics | 2 | $1,320 |
| Abbott | 68 | $1,169 |
| Nevro Corp. | 7 | $786 |
| Baylis Medical Technologies Inc. | 3 | $779 |
| Relievant Medsystems, Inc. | 6 | $424 |
| Stryker | 3 | $248 |
| Si-bone, Inc. | 10 | $219 |
| Intrinsic Therapeutics | 4 | $212 |
| Arthrex | 2 | $161 |
| Cerapedics Inc. | 2 | $157 |
| Providence Medical Technology, Inc. | 3 | $149 |
| Aesculap, Inc. | 6 | $105 |
| Johnson & Johnson(2 entities) | 3 | $94 |
| Orthofix Medical, Inc. | 2 | $86 |
| CTL Medical Corporation | 1 | $75 |
| Baxter Healthcare | 2 | $48 |
| Medacta USA, Inc. | 1 | $43 |
| Arteriocyte Medical Systems, Inc. | 2 | $38 |
| Sanara Medtech Inc. | 1 | $28 |
| Surgalign Spine Technologies, Inc. | 1 | $24 |
| Imperative Care, Inc | 1 | $24 |
| Biotronik NRO, Inc. | 1 | $22 |
| Stimwave Technologies Incorporated | 1 | $20 |
| Integra Lifesciences Corporation | 1 | $17 |
| Siemens Medical Solutions USA, Inc. | 1 | $15 |
| Pacira Pharmaceuticals Incorporated | 1 | $15 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
| Nalu Medical, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MazorX - Renaissance$39,346
- MAZOR X SYSTEM$27,394
- CLYDESDALE$14,741
- AnchorKnot$10,400
- DIVERGENCE-L$10,151
- Alpine XC$9,539
- Evoke$9,005
- CD HORIZON SPINAL SYSTEM$8,284
- Mazor X Stealth Edition$6,681
- PIVOX Oblique Lateral Spinal System$5,739
- Pulse$5,641
- CD HORIZON$2,390
- NRG needle$1,432
- Intracept$881
- Senza Spinal Cord Stimulation System$453
- Excelsius - GPS$370
- BARRICAID ACD (ANNULAR CLOSURE DEVICE)$278
- O-ARM$250
- R&D Product$200
- ANTERALIGN SPINAL SYSTEM WITH TITAN NANOLOCK SURFACE TECHNOLOGY$173
How this compares
Too few neurosurgery providers in North Carolinato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 14 | $79 |
Paid to pharmacies, not to this prescriber.
Other neurosurgery in Wilmington
- Stephen HarwardDurham$4K
- Stephen DalrympleNew Bern$732
- Mark HeldNew Bern$708
- Alexa BramallDurham$538
- Michael DirksPinehurst$216
- Matthew EwendChapel Hill$0
- Herbert FuchsDurham$0
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.